Researchers from Sahlgrenska Academy, University of Gothenburg, have found that a commonly used drug to treat anemia in heart failure patients does not improve patients’ health, nor does it reduce their risk of death from heart failure. Results of the international study were published by The New En more
To use all functions of this page, please activate cookies in your browser.
